Small (8) |
2017 |
United States |
Cross-sectional |
Costs of CKD treatment |
The costs of patients with CKD who do not go through dialysis are high and may be equal to or higher than those of cancer or CVA patients. |
Damien (9) |
2016 |
United States |
Cross-sectional |
Costs of CKD treatment |
Therapeutic follow-up before and after the beginning of dialysis and the managing of comorbidities are potential sources of savings in CKD care. |
Eriksson (10) |
2016 |
Sweden |
Cohort |
Costs of CKD treatment |
In comparison with the general population, the average yearly costs for CKD treatment are higher in all its modalities. |
Anutrakulchai (11) |
2016 |
Thailand |
Cross-sectional |
Clinical outcomes and treatment costs for CKD |
The group of hospitalized CKD patients who presented the fewest benefits and highest mortality was composed of farmers, low-income, and unemployed individuals. |
Silva (12) |
2016 |
Brazil |
Environmental |
Socioeconomic and mortality aspects for patients with CKD |
Men and the elderly presented the highest mortality. Associated with a high prevalence, kidney transplant (deceased donor) and HD presented the highest costs. |
Turchetti (13) |
2016 |
Italy |
Cross-sectional |
Social cost per CKD patient stages 4-5 pre-dialysis |
The indirect and non-medical direct costs from CKD treatment were similar to the direct costs. |
Kerr (14) |
2016 |
England |
Cross-sectional |
Cause, site, and hospital costs related to the death of CKD patients |
The primary causes for the death of CKD patients were not kidney related. Deaths at home are associated with a reduction of hospital costs. |
Roggeri (15) |
2016 |
Italy |
Retrospective cohort |
Costs of CKD treatment |
CKD is associated with a high economic burden and the beginning of dialysis with an increase in direct costs with health care. |
Mendu (!6) |
2016 |
United States |
Retrospective cohort |
Rational clinical criteria for the diagnosis of CKD. |
Some clinical criteria can guide the diagnosis of CKD and reduce its costs. |
Silva (17) |
2016 |
Brazil |
Cost analysis/Literature review |
Costs of CKD treatment |
Kidney transplant stood out as the best alternative from a financial and clinical point of view, under the perspective of the Unified Health System (SUS). |
Kulkarni (18) |
2015 |
India |
Cross-sectional |
Costs of CKD treatment |
The costs of HD in India are high when compared with the per capita income in the country. |
Atapour (19) |
2015 |
Iran |
Cross-sectional |
Costs of CKD treatment |
PD presents a lower cost lower than HD. |
Ferguson (20) |
2015 |
Canada |
Cost models |
Operation costs for dialysis units |
HD units in remote areas are more expensive, per patient, than hospital HD in urban areas. |
Francis (21) |
2015 |
Peru |
Cross-sectional |
CKD demographics |
The high prevalence rates of CKD in Lima and Tumbes are compatible with high-income countries. |
Takura (22) |
2015 |
Japan |
Cost-effectiveness analysis |
Cost-effectiveness of CKD treatment. |
Hemodiafiltration is a cost-effective therapy. |
Wyld (23) |
2015 |
Australia |
Cohort |
Costs of CKD treatment |
CKD patients spend 85% more on health treatments and 50% more government subsidies than individuals with no CKD, and costs rise as the disease progresses. |
Ozieh (24) |
2015 |
United States |
Cross-sectional |
The costs for CKD treatment on DM patients |
CKD significantly contributes to the treatment costs for individuals with DM. |
Kent(25) |
2015 |
England |
Cohort |
Costs of CKD treatment |
RRT and vascular events are the leading causes of the rising costs in CKD treatment. |
Brunelli (26) |
2015 |
United States |
Retrospective cohort |
Costs for CKD treatment in individuals with autosomal dominant polycystic kidney disease. |
The use and costs of health care for patients with autosomal dominant polycystic kidney disease and CKD in the terminal stage in dialysis are high. |
Blanchette (27) |
2015 |
United States |
Cross-sectional |
Costs for CKD treatment in individuals with autosomal dominant polycystic kidney disease. |
Patients with autosomal dominant polycystic kidney disease presented higher rates of renal procedures, which can contribute to the rising costs of treatment. |
Medway (28) |
2015 |
Australia |
Qualitative |
Financial impact of CKD in children |
For parents, the impossibility of keeping their jobs combined with medical and non-medical expenses where the primary factors with a financial impact. |
Menezes (29) |
2015 |
Brazil |
Cross-sectional/retrospective cohort |
Costs of CKD treatment |
A considerable increase in the number of HD sessions and their cost was found, from 2008 to 2012. |
Nassir (30) |
2015 |
United States |
Cohort |
Costs of CKD treatment |
No association was found between the relative costs of the treatment and the failure of the kidney grafts. |
Villarreal-Rios (31) |
2014 |
Mexico |
Cross-sectional |
Costs of CKD treatment |
The high costs of CKD pose a serious problem for healthcare services and families. CAPD is the most cost-efficient option for both. |
Satyavani (32) |
2014 |
India |
Cross-sectional |
The costs for CKD treatment on DM patients |
The direct costs of hospital admissions for treating CKD are considerably higher than those of the patients who suffer from the complication. |
Lorenzo-Sellares (33) |
2014 |
Spain |
Cohort |
Costs of CKD treatment |
HD is five times more expensive than the treatment for advanced stages of CKD and three times the costs for kidney transplantation. |
Moura (34) |
2014 |
Brazil |
Environmental |
Incidence and prevalence of patients on dialysis who rely on public financing |
During the time of the study, there was a constant increase in incidence, and prevalence rose, especially amongst the elderly. |
Gador-Whyte (35) |
2014 |
Australia |
Cross-sectional |
Costs for implementing protocols for CKD and DM treatment |
Adherence to best practices for DM and CKD treatment was compromised by inadequate financing and matters related to the workforce. |
Karopadi (36) |
2014 |
Italy |
Meta-analysis |
Costs of CKD treatment |
Even in the absence of a market for the local production of PD equipment, it is possible for a country to save with the provision of PD. |
Vupputuri (37) |
2014 |
United States |
Retrospective cohort |
The costs for CKD treatment on DM patients |
The progression of CKD in DM type 2 patients substantially increases treatment costs. |
Kadam (38) |
2013 |
England |
Cross-sectional |
Treatment costs for chronic diseases |
Multimorbidity is associated with a broad variety of treatments and different costs. CKD is one of the diseases with the highest and most expensive impact in healthcare. |
Coentrão (39) |
2013 |
Portugal |
Retrospective cohort |
Costs of CKD treatment |
Compared with HD, PD requires fewer resources over the first year of treatment. |
Essue (40) |
2013 |
Australia |
Cross-sectional |
Costs of CKD treatment |
A considerable proportion of the patients face difficulties due to the high costs associated with the treatment and managing od CKD. |
Erdem (41) |
2013 |
United States |
Cross-sectional |
Treatment costs for chronic diseases |
People with chronic diseases represent a disproportionate share of Medicare payments, both for Part A and for Part B, over a period of two years. CKD is among the most expensive chronic diseases, in both parts. |
Ramachandran (42) |
2013 |
India |
Cohort |
Costs of CKD treatment |
Kidney transplant is associated with catastrophic spendings and leads most patients who are treated in a public hospital to a serious financial crisis, as well as to school evasion and loss of employment. |
Chiroli (43) |
2012 |
Multicenter (Europe) |
Retrospective cohort |
Costs of CKD treatment |
Secondary hyperparathyroidism increases the financial burden of CKD in Europe. |
Kerr (44) |
2012 |
England |
Cross-sectional |
Costs of CKD treatment |
The financial impact of CKD is high, with high costs related to RRT and cardiovascular complications. |